<DOC>
	<DOCNO>NCT01011322</DOCNO>
	<brief_summary>The participation clinical study last approximately 21 week 1 week screen period 12 week treatment duration . If study doctor find , patient disease significantly improve he/she enter treatment free follow-up period 8 week . In total study consist 5 6 clinical visit ( V1 - V6 ) 1 telephone follow-up call .</brief_summary>
	<brief_title>A Study Investigate Efficacy LT-02 Patients With Mesalazine Refractory Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<criteria>Men woman 18 year old give write Informed Consent Patients proven ulcerative colitis Active disease course last 6 week longer bloody diarrhea Patients inadequate response treatment mesalazine document intolerance mesalazine . Infectious colitis , include cytomegalovirus Clostridium difficile induce colitis , Crohn 's disease , Colitis due reason ulcerative colitis like know diverticulitis , radiation colitis , ischemic colitis , microscopic colitis , indeterminate colitis , Treatment investigational medicinal product within 3 month prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>